Abstract: The ulcerated papules of cutaneous leishmaniasis represent an unusual form of granulomatous dermatitis caused by Leishmania species, a protozoan transmitted by sandfly bites. As the disease is not native to North America, clinical suspicion is partially based on a compatible travel history and may result in a biopsy. The key role of standard morphology is the identification of Leishmania organisms, supplemented by Giemsa and/or CD1a immunostaining. Histologically, the organism may be confused with Histoplasma species, which is resolved by staining with methenamine silver or PAS. Four cases of cutaneous leishmaniasis are presented for which organisms were present in 3; polymerase chain reaction and DNA sequencing for speciation done by the Center for Disease Control and Prevention (CDC) was confirmatory in 3 cases, including the one case without histologically identifiable organisms. Rare unexplained cases of cutaneous leishmaniasis without a travel history have been reported outside endemic areas. The present cases emphasize the importance of diagnostic awareness of unusual infections such as this in the context of political unrest, ease of international travel, climate change and the possible expansion of geographic vector distribution. In the morphologic absence of organisms, the diagnosis may require molecular techniques, currently available on a referral basis to pathologists without charge from CDC.
C utaneous leishmaniasis is caused by a flagellated protozoan transmitted by the bite of a female sandfly. The clinical and demographic details of this disease, predominantly affecting immunocompetent individuals, are recognized by the WHO as a Neglected Tropical Disease. 1,2 This is a non-lifethreatening disease with the potential for social stigmatization due to the possible development of disfiguring scarring. The ∼1.2 million new cases of cutaneous leishmaniasis reported annually involve > 20 species of Leishmania, each of which is consistently transmitted by a specific sandfly 1,2 and result globally in the infection of a total of as many as 12 million people in > 90 countries. Only active disease is included in incidence calculations but the impact of refugees from regions of political conflict, global climate change and ease of international travel may obscure actual numbers and disease sequelae. 3 The geographic expansion of the sandfly vector may be a future factor.
Humans and other animals (eg, canines and rodents) serve as reservoirs for the organism. During a blood meal, Leishmania emanate from the sandfly's obstructed gastrointestinal tract in promastigote phase as elongated, flagellated organisms 5 to 14 µm in length. Within the human host, they are converted to smaller (2 to 4 µm) amastigote or nonflagellate forms where they are ingested by host histiocytes and initiate an intense granulomatous inflammatory reaction. Simultaneous to injecting organisms at the time of the bite, amastigotes are reaspirated by the sandfly to be again transformed into promastigotes and continue the cycle. This human-sandfly-human cycle is therefore both zoonotic and anthroponotic.
Geographically, 2 areas are principally affected: (1) Old World (Asia, Africa, Southern Europe, and the Middle East); and (2) New World (Mexico, Central, and parts of South America). The sandfly vector is Phlebotomus in Old World forms and Lutzomyia in New World. In either setting, the sandfly itself is small and may penetrate standard mosquito netting; its bite may be barely felt. The known endemic regions of cutaneous leishmaniasis notwithstanding, rare instances of this disease have been encountered outside endemic areas. A recent case from Mendoza, Argentina was > 800 km from the closest endemic region. 4 Reports in the United States are 5 There has even been a recent case report from North Dakota. 6 Although the geographic expansion of the vector is a consideration, the source of the vector in these cases is unknown. The present report describes 4 patients encountered in a general pathology practice in a major US urban setting, considerably removed from an endemic region for this disease. Clinical uncertainty prompted a biopsy in each case. Arguably exotic in this setting, an awareness of the disease, a travel FIGURE 1. A, Case 1: a 10-year-old male. Small erythematous papule on the right cheek. B, Case 1: intense mixed inflammatory infiltrate principally in the papillary dermis but extending deep into the reticular dermis and superficial subcutis. C, Case 1: inflammatory nodule in the papillary dermis with lymphocytes, multinucleated giant cells and histiocytes with groups of small amastigote organisms indicated by a dark nucleus-type structure.
inquiry, the histologic recognition of the organism and the initiation of molecular study may be collectively diagnostic.
MATERIALS AND METHODS
Following Institutional Review Board approval, the surgical pathology records of the North Shore University Health System (a 4 hospital network in north suburban Chicago) were searched between January, 2010 and August, 2017. All histologic slides, special stains, office records, and outside consultation reports were reviewed. Four patients were recovered. Clinical photographs were available for all 4. Formalin-fixed paraffin-embedded tissue was routinely examined by hematoxylin and eosin (H&E) and a variety of readily available special stains including Giemsa, methenamine silver and acid fast. In additionally, immunostaining for CD1a (Cell Marque, Rocklin, CA) was done in cases 1, 2, and 4. In all cases, material for culture, polymerase chain reaction (PCR) and DNA sequencing examinations was forwarded to the Center for Disease Control and Prevention (CDC). These studies are available at no charge to contributing pathologists.
RESULTS
The clinical features are summarized in Table 1 . There were 3 adult females and 1 male child, ages ranging from 10 to 82 years. Positive travel histories were obtained in each case. Two patients had been to Israel, one to Morocco and one to Peru. Exposed body areas were affected by erythematous papular lesions, appearing within weeks to up to more than a year after presumed exposure (Fig. 1A) . The lesions often ulcerated and, in case 2, had already crusted by the time of clinical presentation ( Fig. 2A) . Clinical diagnostic uncertainty led to punch biopsies of the lesions in each case.
The pathologic features are summarized in Table 2 . All 4 cases demonstrated intense, mixed inflammatory infiltrates of lymphocytes, histiocytes, multinucleated giant cells, and noncaseating granulomas occupying the papillary and reticular dermis, focally extending into the subcutis (Figs. 1B, 2B, 3A, B). Organisms were identified by routine H&E staining (Figs. 1C, 2C ) in 3 of the 4 cases and further highlighted by a Giemsa stain (Fig. 4A ). They were characterized by a small, round shape with a peripheral nucleus; neither axonemes nor kinetoplasts were apparent. PAS and GMS stains were uniformly negative. An immunostain for CD1a was done in 3 cases and was positive in 1 (Fig. 4B) . The CDC confirmed Leishmania by immunostaining using an antibody to Leishmania donovani infantum in case 1. Real-time PCR and DNA sequencing in cases 2 to 4, respectively, identified Leishmania tropica, Leishmania major, and Leishmania braziliensis; culture in cases 3 and 4, confirmed L. major and L. braziliensis, respectively.
DISCUSSION
There are 3 clinical presentations of leishmaniasis: cutaneous, mucocutaneous, and visceral (disseminated). Cutaneous and mucocutaneous forms are localized and eventually heal by scarring. Unsurprisingly, exposed body sites are most at risk as the portal of entry from a sandfly bite. More than 50% of cutaneous disease is located on the head and neck as in 2 of the present cases. Grossly, the lesions encountered here were typical, characterized by papules or confluent nodules which were intensely inflamed and even ulcerated. Most such lesions spontaneously heal over a period of months occasionally resulting in socially stigmatizing scars. 3 †Identification by real-time PCR and DNA sequencing by CDC. According to the CDC website, the method is based on PCR amplification using generic primers that amplify a segment of the rRNA internal transcribed spacer 2 from multiple Leishmania species. DNA sequencing analysis is performed on the amplified fragment for species identification (www.cdc.gov/dpdx/leishmaniasis/index.html). Histologically, all 4 cases reported here exhibited histologic features of the active phase of disease with numerous organisms present in 3: a mixed, typically intense, and focal granulomatous reaction involving the entire dermis, focally extending into the subcutis and composed of mononuclear cells, for example, lymphocytes, prominent histiocytes, and multinucleated giant cells. Organisms were identified within histiocytes in 3 cases. In a nonendemic context, a prospective suspicion or prior histologic examination would be required to initiate smears or culture; hence, the diagnosis will often depend on thorough evaluation of routine formalin-fixed paraffin-embedded material.
The natural course of the disease is measured in months, 3 although there is a time spectrum. The presence of organisms in the present cases suggests that the active phase of disease may be more than several months, as biopsies were obtained as long as 1.5 years after clinical onset. It is assumed that all 4 cases resulted from international travel. L. tropica and L. major were identified in cases 2 and 3, respectively, by PCR; cultures and PCR were positive in cases 3 and 4 for L. major and L. brazieliensis, respectively.
The organisms in case 1 were morphologically typical for Leishmania species, although definitive speciation was compromised due to cross reactivity of the L. donavani infantum antibody with other Leishmania species and some Toxoplasma species as well as the lack of subsequent sufficient material for more precise identification by culture or PCR.
In the acute phase of disease with readily apparent organisms, the major differential diagnosis in a nonendemic setting, especially in the Midwest, is histoplasmosis. Morphologically, the yeasts of Histoplasma species and the amastigotes of Leishmania are about the same size (2 to 4 µm), are found within histiocytes and have a similar rounded appearance with a peripherally placed nuclear body (Fig. 5A) . The kinetoplast characteristic of Leishmania, a small pyknotic body separate from the nucleus, may be identified in paraffin-embedded tissue sections and may be demonstrated on smears or imprints. 7 None were identified in the present cases. Axonemes, the ciliated structures emanating from one pole of the organism, are characteristic of the promastigote phase and as such exists only in the gastrointestinal tract of the sandfly. They are not apparent on tissue sections from infected humans, although they may be seen in culture derived smears. The distinction between these 2 organisms is easily resolved using standard methenamine silver or PAS stains, which will stain Histoplasma yeast forms but not Leishmania organisms (Fig. 5B) . The reverse will be true with a standard Giemsa stain.
In addition, Leishmania species may yield a positive reaction with immunostain CD1a, as exhibited in case 2. Because of scant material in the tissue block of case 1, a preexisting H&E slide was destained and then reprocessed for immunostaining, which was unsuccessful in demonstrating the organism. The utility of immunostaining for CD1a is a relatively recent observation although there is not a consistently positive result. The antibody may be less sensitive in New World cases, 8 possibly exemplified by the negative reaction in case 4. As CD1a antibody is commonly associated with surface antigens on histiocytes and dendritic cells, the explanation for its reactivity associated with the organism is speculative. It is possible that the surface of the amastigote and the plasma membrane of a presenting or phagocytic cell share an antigen. Alternatively, the organism may retain a surface antigen from a phagocyte following ingestion. Finally, not all commercially available CD1a clones react identically which may account for staining variability among various organisms. Diagnostic confirmation may require PCR and DNA sequencing for speciation, especially in the absence of organisms altogether. 8 Cutaneous leishmaniasis remains a consideration in the evaluation of granulomatous dermatitis and may be more challenging when granulomas are accompanied by dense scarring, since intact organisms are not present. 9, 10 Recently, PCR has been directed toward mitochondrial kinetoplast DNA, 2,10,11 including one report of 130 cases of chronic granulomatous dermatitis without morphologically discernible organisms in which 27 cases were positive, 10 suggesting antigenic persistence in some form long after the morphologic disappearance of the organism. In case 3, PCR study did establish the diagnosis in the setting of granulomatous dermatitis despite the histologic absence of organisms.
There are specific media requirements for the successful laboratory culture of Leishmania organisms and a positive culture was in fact achieved in cases 3 and 4 from CDC, but only after a prior biopsy had been histologically evaluated and the eventual diagnosis considered. Special molecular techniques are useful in speciation, but these are not practical prospectively in nonendemic areas. Organism identification was further confirmed in all cases by the CDC either by immunohistochemistry or PCR, further emphasizing that molecular techniques for rare diseases are available from reference laboratories only. In the diagnosis of infectious disease, geographic location is a critical clinical clue. Global travel, climate change, the possibility of vector expansion and refugee migration will continue to influence the occurrence of infectious processes outside their usual regions. The contributions to diagnosis by standard morphology should be seen as primary inasmuch as microbiologic and molecular procedures may require more time, may be unsuccessful or material may not even be submitted.
